Kevin O’Brien is a Managing Director of CCMP Capital Advisors, LP, a New York-based private equity firm, and a member of its Investment Committee. Mr. O’Brien has been deeply involved in, and served on the board of CCMP investments including Eating Recovery Centers (behavioral treatment for eating disorders), CareMore Medical Enterprises (Medicare Advantage health plan), LHP Hospital Group (short-term acute care hospital company focused on JVs with larger health systems), Medpace (contract research organization focused on human trials primarily for biotech companies), National Surgical Care (ambulatory surgery centers), Infogroup (marketing data services), and La Petite Academy (early childhood education).
Prior to joining JP Morgan Partners, CCMP’s predecessor firm, in 2000, Mr. O’Brien worked in investment banking in the high yield capital markets and banking groups at Chase Securities and Chemical Securities.
Prior to that, he was a Commissioned Officer in the U.S. Navy from 1988 to 1992 where he served as a Surface Warfare Officer.
Mr O’Brien is currently an investor and board member at EmOpti Inc, a founder-led tele-health business focused on workflow improvements in health systems and Memorial MRI, a Texas-based freestanding imaging center business. He also serves as a senior advisor and audit committee member for the US Diplomatic Studies Foundation, a Washington DC based 501(c)(3) that provides support for a rigorous, effective, and efficient State Department training continuum that prepares national security leaders at every stage of their careers.
Mr. O’Brien holds a B.A. from the University of Notre Dame and an M.B.A. from the Wharton School of the University of Pennsylvania.